Clinical Validation Gap

“Buyers need proof your product works, and you do not have it yet.”

Structural failure pattern in healthcare B2B

59 companies failed due to clinical validation gap in the Stressline corpus.

Deaths

59

Funding Raised by Companies That Failed

$4.3B

Sub-Vertical Breakdown

Digital Therapeutics & DTx17 (29%)
Clinical Workflow & Documentation14 (24%)
Other Healthcare B2B14 (24%)
Pharmacy Technology & Delivery4 (7%)
Health Data Integration & Interoperability3 (5%)
Primary Care & Employer Health2 (3%)
Compliance & Regulatory2 (3%)
Care Navigation & Consumer Health1 (2%)
Behavioral Health & Mental Health1 (2%)
remote_patient_monitoring1 (2%)

Founding Year Timeline

2010
2011
2012
2014
2022

59 companies, 151 failure dimensions coded, 2010–2022.

Related failure patterns

Outspent by bigger competitorsProduct claims exceeded actual capabilitiesCouldn't get paid by insurance

59 companies hit clinical validation gap. Will yours?

Stress-test your thesis →

Get Alerts for This Pattern

New data gets coded regularly. Get notified when this failure pattern updates.

Related methodology

All failure patterns →How the corpus is built →How scoring works →

Data sourced from SBIR/STTR databases, SEC EDGAR filings, ClinicalTrials.gov, CMS data, and founder postmortems. Coded using the Gioia qualitative methodology. Read the methodology.